RMB Products Enters Life Sciences Market

In April 2018, RMB announced the launch of CryoVault™ (https://www.meissner.com/products/cryovault-freeze-thawplatform). The product, a proprietary, scalable, robust,  single-use freeze and thaw platform for the storage of high value biopharmaceuticals, was developed in partnership with Merck.  RMB has partnered with Meissner Filtration Products, a leading biopharma equipment supplier, as its exclusive distributor to market the system. The Cryovault system has significant advantages over competing flexible packaging solutions.  The platform is scalable up to volume requirements of 75 L.  Further, CryoVault™ uses robust rigid wall single-use assemblies to protect your product from fill to dispense ensuring fluid integrity which can be a challenge with flexible packaging.

This represents RMB’s first major entry into the life sciences space, a market MCM believes RMB can grow into through leveraging its unique high purity plastics rotational molding capabilities.

Capital ideas,
delivered to your inbox

Recent Posts
View All

Cleveland, OH, April 26, 2021 - MCM Capital Partners (“MCM”), a lower middle market private equity fund, is pleased to announce the sale of First Impression Ironworks (“FII”), a vertically integrated designer, manufacturer and installer of custom ornamental ironwork including decorative security doors, iron entry doors, gates, staircases, rails and other custom iron products. MCM...

It is with a heavy heart, we announce the passing of Mal Mixon, long-time mentor, friend and one of MCM’s founders. 

June 2020 – Torsion Group Corp (“TGC”) is a manufacturer and distributor of garage door parts and accessories. For the past few years, one of TGC’s strategic initiatives has been vertically integrating to bring more manufacturing inhouse, giving the company more control over its supply chain while enhancing profitability. To that end, TGC purchased a...

An unexpected economic downturn can alter a business owner's exit planning timeline. Fortunately, a multitude of options exist to bridge valuation gaps when they arise.